Beta
34888

Study of Galectin 3 and Matrix Metalloproteinase -9 as Prognostic Markers in Colon Cancer

Article

Last updated: 24 Dec 2024

Subjects

-

Tags

-

Abstract

Objectives: The present study was carried out to evaluate the diagnostic role of
galectin 3 and matrix metalloproteinase 9 in 50 consecutive newly diagnosed colon
cancer patients, who presented to the Outpatient Clinic of the NCI over the period
2011-2012 and to compare their serum levels before treatment with those of 15
benign colon lesions patients, 15 normal controls subjects, and in 16 patients of the
cancer colon group after treatment. Also, to compare these studied markers with
CEA, CA 19.9 and some prognostic factors of cancer colon. Methods: Serum
concentration of CEA and CA19.9 were evaluated using Axsym and MMP9 and
Galectin 3 antigen were assessed using ELISA technique. Results: Serum levels of
MMP9, CEA ,and CA 19.9 showed highest results in the malignant group before
treatment, followed by the patient group with benign lesion, then the malignant group
after treatment and lastly comes the control group. While galectin 3 showed the
highest results in the malignant group, followed by the benign then the control and
lastly comes the after treatment group. Diagnostic performance of all the studied
markers at the chosen cutoffs, CEA (21 ng/ml), CA19.9 (58 U /ml), MMP9 (90.9
ng/ml) and galectin 3 (4.8 ng/ml),galectin 3 showed the highest sensitivity, followed
by CEA, and then CA19.9 and lastly MMP9 (96.9%, 92.3%, 81.5% and 75.4%
respectively). As regards specificity % CEA, CA19.9 and MMP9 showed 100%
specificity each, while galectin 3 showed relatively lower specificity % (90.3%).
Galectin 3 and CEA showed comparable high diagnostic accuracy (94.8%) followed
by CA19.9 (87.5%) then MMP9 (83.3%). On comparing diagnostic performance for
the studied tumor markers in double combinations, the best sensitivity (98.5 %) was
obtained when combining galectin 3 & CA19.9 at cut offs (4.8 ng/ml - 58 U /ml)
respectively and galectin 3 & MMP9 at cutoffs (4.8 ng/ml – 90.9ng/m) respectively.
As regards specificity, the double combination between CEA & CA19.9 at cut offs (21
ng/ml - 58 U /ml)) respectively and MMP9 & CA19.9 at cut offs (90.9 ng/ml - 58 U
/ml) respectively showed the highest specificity of 100% each, on studying the
correlation between all the studied tumor markers, there were significant positive
correlations between CEA & CA19.9 , CEA & Galectin 3, CEA & MMP9, CA19.9 &
Galectin 3, CA19.9 & MMP9 and MMP9 & Galectin 3 (p=0.0001) each.

DOI

10.21608/besps.2013.34888

Keywords

galectin 3, MMP9, Colon cancer, tumor marker

Authors

First Name

Mohamed

Last Name

Badawy

MiddleName

-

Affiliation

Department of Clinical pathology, Faculty of Science - Cairo University, Egypt

Email

-

City

-

Orcid

-

First Name

Iman

Last Name

Abdelgawad

MiddleName

-

Affiliation

Department of Clinical pathology, Faculty of Science - Cairo University, Egypt

Email

-

City

-

Orcid

-

First Name

Asmaa

Last Name

Abdelgawad

MiddleName

-

Affiliation

Department of NCI, Biochemistry, Faculty of Science - Cairo University, Egypt

Email

-

City

-

Orcid

-

Volume

33

Article Issue

1

Related Issue

5749

Issue Date

2013-06-01

Receive Date

2013-06-15

Publish Date

2013-06-01

Page Start

35

Page End

52

Print ISSN

1110-0842

Online ISSN

2356-9514

Link

https://besps.journals.ekb.eg/article_34888.html

Detail API

https://besps.journals.ekb.eg/service?article_code=34888

Order

3

Type

Original Article

Type Code

567

Publication Type

Journal

Publication Title

Bulletin of Egyptian Society for Physiological Sciences

Publication Link

https://besps.journals.ekb.eg/

MainTitle

Study of Galectin 3 and Matrix Metalloproteinase -9 as Prognostic Markers in Colon Cancer

Details

Type

Article

Created At

22 Jan 2023